---
title: "CA02825 Ixekizumab (Taltz(r))"
ocid: "ocds-r6ebe6-0000797440"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000797440"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000797440.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000797440.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-04-30"
---

# CA02825 Ixekizumab (Taltz(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000797440

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000797440)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000797440.json)

## Summary

The procurement process led by The Common Services Agency, known as NHS National Services Scotland (NSS), involved the contracting for the supply of ixekizumab (Taltz®) for new patients in NHS Scotland. This process falls under the health industry category and is based in Edinburgh, UK, with a completion status. The title of the tender was "CA02825 Ixekizumab (Taltz®)," and the procurement method was limited, executed without prior publication of a call for competition. This decision was backed by the protection of exclusive rights under the Public Contracts (Scotland) Regulations 2015. The contract, valued at £1,142,153 GBP, was awarded to Eli Lilly and Company and signed on 28th April 2025. The framework agreement is intended for an eight-month duration.

This procurement presents an opportunity for large-scale pharmaceutical firms specialising in innovative medications protected by intellectual property rights. Businesses well-suited for such tenders are those that possess exclusive distribution rights and the capability to supply specialised pharmaceutical products. This award aligns with a strategic growth avenue for pharmaceutical companies aiming to extend their market presence within the UK healthcare sector, particularly those focused on government contracts. Having exclusive patents or intellectual properties positions businesses to enter similar procurement processes where competition is limited due to regulatory conditions, potentially fostering business growth through high-value contracts with national health services.

## Notice

Supply of ixekizumab for new patients treated in NHS Scotland

### Lot Information

Lot 1

Supply of Ixekizumab (Taltz(r)) to NHS Scotland. The Authority has awarded this framework as a single supplier framework agreement to one (1) Framework Participant.

### Procurement Information

The medicines awarded to the individual framework agreements are protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR529252 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 30 Apr 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 28 Apr 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,142,153 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ELI LILLY |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 30 Apr 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR529252

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR529252
  CA02825 Ixekizumab (Taltz(r)) - Supply of ixekizumab for new patients treated in NHS Scotland

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000797440
- https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000797440. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000797440.json.